The shoe thing blindsided me completely. I'd worn the same size for twenty years, then suddenly every pair I owned felt like it belonged to someone else. Nobody mentioned feet when they listed menopause symptoms, so I assumed I was just buying bad shoes. Finding out there was a genuine physiological reason behind it — ligaments, estrogen, arch collapse — was somehow both frustrating and an enormous relief.
Learn more about Rose →Estrogen plays a direct role in maintaining ligament tensile strength throughout the body, including the plantar fascia and the network of ligaments that support the longitudinal arch of the foot. When estrogen levels fall during perimenopause, those ligaments become laxer and less able to resist the load of body weight with each step. The arch gradually flattens — a process called pes planus or acquired adult flatfoot — and the foot spreads wider as a result, often increasing shoe size by a half to full size.
The metatarsal bones at the front of the foot are held together in a transverse arch by ligaments that, like all connective tissue, depend partly on estrogen for their stiffness. As laxity increases, the transverse arch spreads and the forefoot becomes measurably wider. This is why women who have worn the same shoe width for decades suddenly find that formerly comfortable shoes create pressure and pain across the ball of the foot.
The heel and ball of the foot have specialized fat pads that absorb impact — and their thickness is influenced by both age and hormonal status. Research shows the plantar fat pad thins significantly in postmenopausal women compared with premenopausal women of similar weight, reducing shock absorption with every step. Hard floors, thin-soled shoes, and long periods of standing become disproportionately painful because the natural cushioning that once existed is simply no longer there.
Estrogen stimulates collagen synthesis, and collagen is the primary structural protein in tendons, including the Achilles tendon and the plantar fascia. After menopause, collagen production drops by roughly 30 percent in the first five years, making these structures less elastic and more vulnerable to microtears and chronic inflammation. This is a key reason why plantar fasciitis and Achilles tendinopathy become dramatically more common in midlife women — and why morning heel pain often appears seemingly out of nowhere.
Hormonal changes during perimenopause tend to redistribute body fat toward the abdomen, and many women also experience modest overall weight gain during this transition. Even a relatively small increase in body weight meaningfully increases the compressive load on foot structures that are already becoming laxer and less cushioned. This combination — more load on weaker, flatter feet — accelerates arch flattening and significantly raises the risk of overuse injuries.
Fluctuating and declining estrogen has a pro-inflammatory effect on joints throughout the body, including the small joints of the toes and midfoot. Women in perimenopause frequently report diffuse foot and ankle aching that does not follow the pattern of a single injury and does not have an obvious mechanical cause. This low-grade inflammatory state is the same mechanism behind the generalized joint pain that many women notice in their hands, knees, and hips during the menopause transition.
Estrogen is protective of bone density, and its decline accelerates bone loss that begins well before the final menstrual period. The metatarsal bones in the foot are among the most common sites for stress fractures in women, and reduced bone mineral density means those fractures can occur with lower levels of repetitive stress than before. A woman who has always run, walked long distances, or stood for hours at work may find she develops foot pain from activities that never troubled her in her thirties.
Estrogen has neuroprotective effects and influences how peripheral nerves process sensation, including in the feet. Some women in menopause report heightened sensitivity or burning sensations in the feet — sometimes diagnosed as metatarsalgia or Morton's neuroma — that may be partly driven by hormonal changes in nerve function rather than purely mechanical compression. This altered nerve sensitivity means shoes that once felt fine can suddenly register as uncomfortable or even painful at normal levels of pressure.
Getting feet professionally remeasured — both length and width — is the most immediate practical step, since wearing the correct size significantly reduces injury risk and discomfort from a structurally changed foot. Supportive footwear with a wide toe box, adequate arch support, and a cushioned sole compensates directly for fat pad thinning and ligament laxity; motion-control or stability features help women whose arches have noticeably flattened. For women already using or considering menopausal hormone therapy, it is worth knowing that estrogen replacement has been shown to slow ligament laxity and improve collagen maintenance, which may modestly slow further structural foot changes over time.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.